A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.

Hu, Junhui; Schokrpur, Shiruyeh; Archang, Maani; Hermann, Kip; Sharrow, Allison C; Khanna, Prateek; Novak, Jesse; Signoretti, Sabina; Bhatt, Rupal S; Knudsen, Beatrice S; Xu, Hua; Wu, Lily

Hu, Junhui; Schokrpur, Shiruyeh; Archang, Maani; Hermann, Kip; Sharrow, Allison C; Khanna, Prateek; Novak, Jesse; Signoretti, Sabina; Bhatt, Rupal S; Knudsen, Beatrice S; Xu, Hua; Wu, Lily.

Hu J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Schokrpur S; Department of Urology and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Archang M; Department of Paediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Hermann K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Sharrow AC; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Khanna P; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Novak J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Signoretti S; Department of Medicine, Beth Israel Deacones Medical Center, Boston, MA 02215, USA.
Bhatt RS; Kidney Cancer Program, Dana-Farber Harvard Cancer Center, Boston, MA 02215, USA.
Knudsen BS; Kidney Cancer Program, Dana-Farber Harvard Cancer Center, Boston, MA 02215, USA.
Xu H; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
Wu L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.